Aurobindo Pharma Q3 net profit drops 10% to Rs 846 crore
Aurobindo Pharma on Thursday reported a 10% year-on-year (YoY) decline in net profit to Rs 846 crore in the third quarter ended December 2023, dragged by US sales. despite strong growth momentum in Europe, growth markets and antiretrovirals segment. The company posted net profit of Rs 940 crore in the corresponding quarter of previous year….